期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Medicine and Data. 2022; 6: (6) ; 129-131 ; DOI: 10.12208/j.ijmd.20220264.

The value of tumor markers in the diagnosis of cervical cancer
肿瘤标志物检测在宫颈癌诊断中的价值探析

作者: 黄龑, 倪翀*,

空军杭州特勤疗养中心 浙江杭州

*通讯作者: 倪翀,单位:空军杭州特勤疗养中心 浙江杭州;

发布时间: 2022-11-17 总浏览量: 27

摘要

目的 探究肿瘤标志物检测在宫颈癌诊断中的临床价值。方法 选取我院48例疑似宫颈癌设定为观察组,另选取同期我院48例体检健康者设定为对照组。两组均进行血清肿瘤标志物检测,对其检测结果进行分析对比。结果 观察组CA125、CEA检测结果明显高于对照组,差异均有统计学意义(P<0.05)。将病理检出结果作为金标准,CA125、CEA联合检测结果的准确性、敏感性、特异性均高于CA125、CEA单一检测结果。结论 在宫颈癌患者诊断过程中,采用CA125、CEA联合检测能取得较佳的效果,对其后续治疗可提供有效依据。

关键词: 肿瘤标志物;宫颈癌;诊断

Abstract

Objective To explore the clinical value of tumor markers detection in the diagnosis of cervical cancer.
Methods 48 cases of suspected cervical cancer in our hospital were selected as the observation group, and 48 cases of healthy people in our hospital were selected as the control group in the same period. Serum tumor markers were detected in both groups, and the results were analyzed and compared.
Results The results of CA125 and CEA in the observation group were significantly higher than those in the control group (P<0.05). Taking pathological detection results as the gold standard, the accuracy, sensitivity and specificity of CA125 and CEA combined detection results are higher than those of CA125 and CEA single detection results.
Conclusion   The combined detection of CA125 and CEA can achieve better results in the diagnosis of cervical cancer patients, and provide effective basis for their follow-up treatment.

Key words: Tumor markers; Cervical cancer; diagnosis

参考文献 References

[1] 许婷.血清肿瘤标志物联合检测在宫颈癌诊断中的临床价值[J].中国冶金工业医学杂志,2022,39(05):620.

[2] 张道玲.肿瘤标志物CA50、CA125、CA199、癌胚抗原联合检测在宫颈癌诊断中的应用价值[J].中国卫生工程学,2022,21(02):292-293+296.

[3] 袁建涛,雷婷.宫颈癌患者血清中肿瘤标志物检测的价值研究[J].国际检验医学杂志,2018,39(06):703-705+709.

[4] 赵东焕.血清肿瘤标志物联合检测诊断早期宫颈癌的效果观察[J].中国卫生标准管理,2021,12(16):87-90.

[5] 张蔚,王启龙.血清肿瘤标志物检测在宫颈癌诊断中的应用价值[J].现代医学与健康研究电子杂志,2020,4(19):88-90.

[6] 贾小村.血清肿瘤标志物联合检测诊断早期宫颈癌的价值分析[J].医学理论与实践,2020,33(02):294-295.

[7] 张军,张莹.肿瘤标志物在宫颈癌的检测联合应用[J].中华肿瘤防治杂志,2018,25(S1):128+130.

[8] 林炜,刘春霞,申昌梅.肿瘤标志物检测在宫颈癌患者中的临床意义[J].医疗装备,2018,31(17):73-74.

[9] 张力忆.宫颈癌患者血清中肿瘤标志物检测的临床价值观察[J].四川解剖学杂志,2018,26(02):59-60.

[10] 秦敏.血清肿瘤标志物联合检测诊断早期宫颈癌的临床价值分析[J].中外女性健康研究,2022(12):192-193.

引用本文

黄龑, 倪翀, 肿瘤标志物检测在宫颈癌诊断中的价值探析[J]. 国际医学与数据杂志, 2022; 6: (6) : 129-131.